Quick Summary:
For decades, Tuberculosis (TB) has posed a significant health challenge globally, invoking the necessity for rapid, precise, and cost-effective diagnostic tests. The global Tuberculosis Testing market is projected to grow from US$2 Billion in 2022 to a robust US$3.1 Billion by 2030, signaling the potent prospects of this industry. The comprehensive market research report on Tuberculosis Testing not only provides crucial insights into the market size and trajectory, but also offers invaluable data on the Culture-Based Tests and Chest X-Ray segments, expected to register substantial growth rates.
Understanding the Tuberculosis Testing market isn't just about knowing global trends, but also appreciating regional dynamics. The U.S. market, already estimated at US$125.8 Million, along with burgeoning markets like China, forecast to reach a remarkable US$397 Million by 2030, is analyzed meticulously. Our report provides a global perspective, while also detailing significant regional markets, such as Japan, Canada, Germany, and especially Asia-Pacific region, projected to reach US$1.3 Billion by 2030.
Distinguished by its exceptional coverage of global competitiveness and key competitor percentage market shares, this market research report is indispensable for senior executives looking to capitalize on the growing Tuberculosis Testing market.
Global Tuberculosis Testing Market to Reach $3.1 Billion by 2030
The global market for Tuberculosis Testing estimated at US$2 Billion in the year 2022, is projected to reach a revised size of US$3.1 Billion by 2030, growing at a CAGR of 5.7% over the analysis period 2022-2030. Culture-Based Tests, one of the segments analyzed in the report, is projected to record 5.9% CAGR and reach US$756.5 Million by the end of the analysis period. Growth in the Chest X-Ray segment is estimated at 4.3% CAGR for the next 8-year period.The U.S. Market is Estimated at $125.8 Million, While China is Forecast to Grow at 6.1% CAGR
The Tuberculosis Testing market in the U.S. is estimated at US$125.8 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$397 Million by the year 2030 trailing a CAGR of 6.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.5% and 3.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.Select Competitors (Total 55 Featured)
- Abbott Laboratories, Inc.
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- bioMerieux SA
- Danaher Corporation
- Cepheid
- Daan Gene Co., Ltd.
- Akonni Biosystems, Inc.
- Anatolia Tani ve Biyoteknoloji Urunleri Ar-Ge San. ve Tic. AS
- Creative Diagnostics
- Accuquikâ„¢ Test Kits
- AID GmbH
- AB ANALITICA s.r.l.
- Bioneovan Co., Ltd.
- CTK Biotech, Inc.
Economic Outlook
The global economic outlook is improving, and growth recovery, albeit on the lower side, is expected for this year and the next. The United States although witnessing slowing GDP growth in response to tight monetary and financial conditions, has nevertheless overcome the recession threat. Easing of headline inflation in Euro area is helping boost real incomes and is contributing to pick-up in economic activity. China is expected to see strong increases in GDP in the coming year as the pandemic threat recedes and the government sheds its zero-COVID policy. With optimistic GDP projections, India remains on-course to emerge into a US trillion economy by 2030, surpassing Japan and Germany.The upturn, however, remains fragile and a number of interlocking challenges continue to run in parallel, such as continued uncertainty around the war in Ukraine; slower than expected decline in global headline inflation; continuation of food and fuel inflation as a persistent economic problem for most developing countries; and still high retail inflation and its impact on consumer confidence and spending. Countries and their governments are showing signs of weathering these challenges, which helps lift market sentiments. As governments continue to combat inflation to get it down to more economically conformable levels by raising interest rates, new job creation will slowdown and impact economic activity. Stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced.
Although corporate investments can likely be held back by inflation worries and weaker demand, rise of new technologies will reverse partially this prevailing investment sentiment. Rise of generative AI; applied AI; industrializing machine learning; next-generation software development; Web3; cloud and edge computing; quantum technologies; electrification and renewables and climate technologies beyond electrification and renewables, will open up the global investment landscape. The technologies hold the potential to drive sizeable incremental growth and value to global GDP in the coming years. The short-term is expected to be a mixed bag of challenges and opportunities for both consumers and investors alike. There is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.
What`s New?
- Special discussions on the global economic climate and market sentiment
- Coverage on global competitiveness and key competitor percentage market shares
- Market presence analysis across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and trademarked research platform
- Complimentary updates for one year
- Access to curated YouTube video transcripts of market sentiments shared by CEOs, domain experts and market influencers via interviews, podcasts, press statements and event keynotes
What is the estimated value of the Tuberculosis Testing Market?
What is the growth rate of the Tuberculosis Testing Market?
What is the forecasted size of the Tuberculosis Testing Market?
Who are the key companies in the Tuberculosis Testing Market?
Report Attribute | Details |
---|---|
No. of Pages | 423 |
Published | December 2023 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 2 Billion |
Forecasted Market Value ( USD | $ 3.1 Billion |
Compound Annual Growth Rate | 5.6% |
Regions Covered | Global |
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- Abbott Laboratories, Inc.
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- bioMerieux SA
- Danaher Corporation
- Cepheid
- Daan Gene Co., Ltd.
- Akonni Biosystems, Inc.
- Anatolia Tani ve Biyoteknoloji Urunleri Ar-Ge San. ve Tic. AS
- Creative Diagnostics
- Accuquikâ„¢ Test Kits
- AID GmbH
- AB ANALITICA s.r.l.
- Bioneovan Co., Ltd.
- CTK Biotech, Inc.